Skip to content

Search for:

Storm Riders Network

Into This World We're Thrown

Facebook
Instagram
Twitter
LinkedIn

MENUMENU

ABOUT
- Mission
- My Story
SCIENCE & RESEARCH
RESOURCES
- Organizations
- News & Publications

Category: Male breast cancer

FDA approves palbociclib for male patients with HR+/HER2-Neg breast cancer

Latest News

Pivotal trials With CDK4/6 & PI3K inhibitors propel progress in HR+ breast cancer
August 14, 2019
Rugo shares insight on intriguing SOPHIA data in HER2+ breast cancer
August 14, 2019
Autophagy inhibition elicits emergence from metastatic dormancy by inducing & stabilizing Pfkfb3 expression
August 14, 2019
Aspirin may help some breast cancer survivors, but changes in DNA may mean harm for others
August 12, 2019

Stay Connected

Subscribe to this blog and receive notifications of new posts by email.

Email Address

Upcoming Events

ASCO-SITC Clinical Immuno-Oncology Symposium

February 6 - February 8
Komen® South Central’s Metastatic Breast Cancer Conference

February 7 - February 8
Best of SABCS- New York

February 8
Immune system & metastasis webinar

February 13 @ 10:00 am - 11:00 am EST

View All Events